Pipeline · Bill → Law
Step 1
Introduced
Apr 28, 2023
Step 2
Referred
May 5, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill requires drug manufacturers to notify the Food and Drug Administration (FDA) if there is an increased demand for certain critical essential medicines that may result in a shortage. Currently, drug manufacturers are required to notify the FDA in the event of a discontinuation or interruption in the supply of prescription drugs that are life-supporting, life-sustaining, or used for a debilitating disease or condition, including those used in medical emergencies, surgeries, or public health emergencies. The bill requires drug manufacturers to also notify the FDA if there is an increased demand for such drugs that lasts for at least six weeks and that may result in a shortage. Manufa...
Timeline · 3 actions
May 5, 2023
Referred to the Subcommittee on Health.
Apr 28, 2023
Introduced in House
Apr 28, 2023
Referred to the House Committee on Energy and Commerce.